Clinical trial Recruiting at 1 site Interventional Ages 18 and up

ANTALGEEK Thess Monitoring for outpatient postoperative pain and recovery

Official title: Evaluation of the Performance and Safety of the ANTALGEEK® Thess Monitoring Medical Device in the Outpatient Management of Acute Pain and Postoperative Recovery - A Single-Center, Randomized, Controlled Proof-of-Concept Study.

Run by Centre Hospitalier Universitaire de Nīmes · NCT07680998 · Data updated 2026-11-12

This study tests whether using the ANTALGEEK Thess monitoring device at home, plus a fixed analgesia plan, helps manage acute postoperative pain in adults after outpatient surgery.

More Chronic Pain trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorCentre Hospitalier Universitaire de Nīmes
Academic / other
Locations1 site (Nîmes, Gard)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedAugust 1, 2026
Study endsDecember 31, 2026
Registry record updatedJuly 8, 2026
Trial IDNCT07680998 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults undergoing outpatient surgery expected to experience moderate to severe postoperative pain and able to participate in three months of follow-up.

Probably not a fit

Patients not receiving meaningful pain improvement or unable to use the telemonitoring device may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study evaluates post-operative follow-up with the Thess Telemonitoring device combined with the ANTALGEEK protocol for managing acute postoperative pain in outpatients. Eligible participants are adults undergoing outpatient surgery likely to experience moderate to severe pain and willing to be followed for three months. The approach emphasizes routine, fixed-schedule analgesia with rescue options, aiming to reduce pain early after surgery and potentially prevent chronic postoperative pain. The study is conducted at Nîmes University Hospital in France under a single lead sponsor with no listed collaborators. Outcomes focus on feasibility, safety, and pain management effectiveness in the outpatient setting.

Why it matters

Potential benefit: If successful, patients may experience better-controlled pain at home and a lower risk of developing chronic postoperative pain.

How similar studies have gone: Other telemonitoring or structured analgesia approaches in postoperative care have shown improvements in pain control and outcomes in some settings, but this specific device/protocol combination is relatively novel here.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients eligible for outpatient surgery.
* Patients undergoing surgery likely to result in moderate to severe pain.
* Patients available for a 3-month follow-up.
* Patients who have provided their free and informed consent.
* Patients who have signed the consent form.
* Patients enrolled in or covered by a health insurance plan.

Exclusion Criteria:

* Patients participating in an interventional RIPH study involving a drug or classified as Category 1.
* Patients in an exclusion period determined by another study.
* Patients under judicial protection, guardianship, or conservatorship.
* Patients unable to express consent.
* Patient for whom it is impossible to provide informed information.
* Pregnant, laboring, or breastfeeding patients.

Where it's running

  • Nimes University Hospital
    Nîmes, Gard, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.